Combining these with patients’ clinical features and tumor markers (for example, CEA) may enhance the effectiveness of diagnosing NSCLC, potentially providing heightened early warning at pre-diagnosis and diagnosis. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.